NEW
YORK, Dec. 30, 2024 /PRNewswire/ -- Baird
Medical (NASDAQ: BDMD), a leading innovator in minimally invasive
microwave ablation (MWA) technology, proudly supported and
participated in the 2024 Guangdong Provincial Parathyroid Disease -
Southern Yue Forum, held in Guangzhou,
China.
This distinguished forum, organized by prominent healthcare
institutions in Guangdong, brought
together esteemed medical experts, researchers, and healthcare
professionals to share insights on advancements in the diagnosis
and treatment of parathyroid diseases. The event served as an
important platform for academic discussions and the exchange of
clinical expertise in the field of endocrine health.
As a sponsor, Baird Medical presented its cutting-edge microwave
ablation technology, designed to deliver precise and efficient
treatment options for endocrine conditions, including parathyroid
diseases. Participants had the opportunity to learn about the
company's approach to minimally invasive therapies, aimed at
optimizing patient outcomes.
"We are pleased to participate in this highly regarded forum,
which reflects our ongoing commitment to supporting medical
advancements in endocrine disease management," said Haimei Wu,
Chairwoman of Baird Medical. "Our focus remains on empowering
medical professionals with innovative solutions that contribute to
improved patient care and clinical outcomes."
The forum provided Baird Medical with the opportunity to engage
with key opinion leaders, foster collaborations, and deepen its
understanding of evolving clinical needs. The company's
participation underscores its commitment to advancing minimally
invasive medical technologies and contributing to the broader
healthcare community in a responsible and impactful manner.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave
ablation (MWA) technology, offering advanced treatment solutions
for conditions such as thyroid nodules, breast disease, uterine
fibroids, and liver cancer. A publicly traded company on NASDAQ,
Baird Medical is dedicated to enhancing patient care through
precision, efficiency, and safety in its innovative medical
devices. For more information, please visit
https://bairdmed.com/
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the United States Private Securities Litigation
Reform Act of 1995. Forward-looking statements are statements that
are not historical facts and generally relate to future events or
Baird Medical's future financial or operational performance. In
some cases, you can identify forward-looking statements by
terminology such as "may," "might," "will," "should," "expect,"
"intend," "plan," "anticipate," "believe," "estimate," "predict,"
"potential," "continue," or the negative of these terms or other
similar expressions.
These forward-looking statements are subject to risks,
uncertainties, and assumptions that could cause actual results or
outcomes to differ materially from those expressed or implied.
These statements are based on estimates and assumptions that, while
considered reasonable by Baird Medical and its management, are
inherently uncertain. Risks and uncertainties may emerge over time,
and it is not possible to anticipate all potential factors that
could affect Baird Medical's business and financial
performance.
Factors that could cause actual results to differ materially
include, but are not limited to: (1) the risk that Baird Medical
may not achieve its expansion goals in the United States, China, or other markets; (2) changes in
economic, regulatory, or market conditions that impact Baird
Medical's operations; (3) the ability to realize anticipated
benefits from ongoing business initiatives or strategic
transactions; (4) regulatory developments and compliance with
applicable laws; (5) risks related to the development,
commercialization, and market acceptance of Baird Medical's
products; and (6) other risks and uncertainties detailed in Baird
Medical's filings with the SEC.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date they
are made. Baird Medical undertakes no obligation to update or
revise forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
law. All forward-looking statements in this press release are
qualified in their entirety by this cautionary statement.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/baird-medical-showcases-innovations-in-endocrine-care-at-2024-southern-yue-forum-302340100.html
SOURCE BDMD
